关于大型或局部晚期乳腺癌患者的¹⁸F-FDG PET/CT预处理成像。 - Suppr

Suppr

超能文献

Concerning pretreatment ¹⁸F-FDG PET/CT imaging in patients with large or locally advanced breast cancer.

作者信息

Groheux David, Hindié Elif

机构信息

Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France.

Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France.

出版信息

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1801-3. doi: 10.1007/s00259-015-3144-0. Epub 2015 Aug 5.

DOI:10.1007/s00259-015-3144-0

PMID:26239284

Abstract

摘要

相似文献

Concerning pretreatment ¹⁸F-FDG PET/CT imaging in patients with large or locally advanced breast cancer.关于大型或局部晚期乳腺癌患者的¹⁸F-FDG PET/CT预处理成像。

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1801-3. doi: 10.1007/s00259-015-3144-0. Epub 2015 Aug 5.

Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.治疗前联合（18）F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描分期对局部晚期乳腺癌放射治疗决策的影响

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):111-7. doi: 10.1016/j.ijrobp.2015.05.012. Epub 2015 May 15.

Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.基础¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为局部晚期乳腺癌患者的预后生物标志物

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1804-13. doi: 10.1007/s00259-015-3102-x. Epub 2015 Jul 9.

Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.使用专用乳腺PET（MAMMI）评估乳腺癌原发肿瘤（18）F-FDG摄取的异质性：一项基于与PET/CT相关性的可行性研究。

Nucl Med Commun. 2014 May;35(5):446-52. doi: 10.1097/MNM.0000000000000072.

Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.俯卧位与仰卧位乳腺 FDG-PET/CT 在评估局部晚期乳腺癌局部区域疾病分布中的应用

Acad Radiol. 2015 Jul;22(7):853-9. doi: 10.1016/j.acra.2015.02.012. Epub 2015 Apr 10.

Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.¹⁸F-FDG PET/MRI、¹⁸F-FDG PET/CT、MRI及CT在复发性乳腺癌全身分期中的评估

Eur J Radiol. 2016 Feb;85(2):459-65. doi: 10.1016/j.ejrad.2015.12.010. Epub 2015 Dec 19.

Performance of FDG PET/CT in the clinical management of breast cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在乳腺癌临床管理中的应用。

Radiology. 2013 Feb;266(2):388-405. doi: 10.1148/radiol.12110853. Epub 2012 Dec 6.

The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.（18）F-FDG PET/CT在乳腺癌及淋巴结转移和微转移诊断中的作用可能有限。

Hell J Nucl Med. 2014 Sep-Dec;17(3):177-83.

A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.18F-FDG PET/CT 检测到的乳腺叶状囊肉瘤肺转移。

Clin Nucl Med. 2014 Mar;39(3):e233-5. doi: 10.1097/RLU.0b013e3182815f9b.

A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.前瞻性评估 2-脱氧-2-[(18)F]氟-D-葡萄糖正电子发射断层扫描和计算机断层扫描在局部进展期胃癌分期中的应用。

Cancer. 2012 Nov 15;118(22):5481-8. doi: 10.1002/cncr.27550. Epub 2012 May 1.

本文引用的文献

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?临床、组织学或免疫组化原发性肿瘤特征是否能转化为II/III期乳腺癌不同的（18）F-FDG PET/CT体积和异质性特征？

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1682-1691. doi: 10.1007/s00259-015-3110-x. Epub 2015 Jul 4.

Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.基线肿瘤18F-FDG摄取及新辅助化疗2周期后的变化对雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌预后具有预测价值。

J Nucl Med. 2015 Jun;56(6):824-31. doi: 10.2967/jnumed.115.154138. Epub 2015 Apr 16.

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.（18）F FDG-PET/CT在预测管腔型乳腺癌预后中的应用

Breast Cancer Res Treat. 2015 Feb;150(1):209-17. doi: 10.1007/s10549-015-3303-9. Epub 2015 Feb 20.

Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.18F-FDG PET/CT 分期和新辅助化疗病理反应对三阴性乳腺癌的预后影响。

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):377-85. doi: 10.1007/s00259-014-2941-1. Epub 2014 Nov 29.

Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.对18F-FDG PET/CT用于40岁以下无症状乳腺癌患者分期的回顾性分析。

J Nucl Med. 2014 Oct;55(10):1578-83. doi: 10.2967/jnumed.114.143297. Epub 2014 Sep 11.

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的早期评估有助于预测三阴性乳腺癌新辅助化疗的结果。

Eur J Cancer. 2014 Jul;50(11):1864-71. doi: 10.1016/j.ejca.2014.04.020. Epub 2014 May 16.

Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.早期监测 luminal HER2 阴性乳腺癌新辅助化疗时使用（18）F-FDG PET 的 5 年预后相关性。

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):416-27. doi: 10.1007/s00259-013-2616-3. Epub 2013 Nov 21.

¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.¹⁸F-FDG PET/CT 与常规检查相比，可为大型乳腺癌的初始分期提供强有力的预后分层。

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):428-37. doi: 10.1007/s00259-013-2595-4. Epub 2013 Nov 7.

HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.HER2 过表达乳腺癌：两周期化疗后 FDG 摄取预测新辅助治疗的结果。

Br J Cancer. 2013 Sep 3;109(5):1157-64. doi: 10.1038/bjc.2013.469. Epub 2013 Aug 13.

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.（18）FDG-PET-CT 检查结果对临床 III 期和 IIB 期乳腺癌的预后影响。

J Natl Cancer Inst. 2012 Dec 19;104(24):1879-87. doi: 10.1093/jnci/djs451. Epub 2012 Dec 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验